Literature DB >> 24722913

Effectiveness of an educational intervention on the management of type 2 diabetic patients hospitalized in Internal Medicine: results from the FADOI-DIAMOND study.

Giovanni Gulli1, Stefania Frasson, Vito Borzì, Andrea Fontanella, Marco Grandi, Claudio Marengo, Antonio Nicolucci, Ruggero Pastorelli, Bruno Solerte, Adriano Gatti, Francesco Cristiano Raimondo, Erminio Bonizzoni, Gualberto Gussoni, Antonino Mazzone, Antonio Ceriello.   

Abstract

Appropriate management of hyperglycemia is crucial for patients with type 2 diabetes. Aim of the FADOI-DIAMOND study was to evaluate real-world management of type 2 diabetic patients hospitalized in Internal Medicine wards (IMW) and the effects of a standardized educational intervention for IMW staff. DIAMOND has been carried out in 53 Italian IMW, with two cross-sectional surveys interspersed with an educational program (PRE phase and POST phase). In PRE phase, each center reviewed the charts of the last 30 hospitalized patients with known type 2 diabetes. An educational program was conducted in each center by means of the "outreach visit," a face-to-face meeting between IMW staff and a trained external expert. Six months after, each center repeated the data collection (POST phase), specular to the PRE. A total of 3,167 patients were enrolled (1,588 PRE and 1,579 POST). From PRE phase to POST, patients with registered anthropometric data (54.1 vs. 74.9 %, p < 0.001) and in-hospital/recent measurement of glycated hemoglobin (48.2 vs. 61.4 %, p < 0.005) increased significantly. After educational program, more patients received insulin during hospitalization (68.3 vs. 63.6 %, p = 0.005). A more relevant variation in glycemia during hospitalization was observed in POST phase than PRE (-22.2 vs. -15.5 mg/dL, p < 0.001), without differences as for occurrence of hypoglycemia (12.3 vs. 11.9 %). A one-shot educational intervention led to persistent improvement in the management of hospitalized patients with type 2 diabetes and to significant better glycemic control. Further studies might evaluate the effectiveness of a more aggressive educational program, on both management and outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722913     DOI: 10.1007/s00592-014-0585-z

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

Review 1.  Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention.

Authors:  A H Abdelhafiz; A J Sinclair
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

2.  The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine.

Authors:  Filippo Pieralli; Cristina Bazzini; Alessia Fabbri; Carlotta Casati; Andrea Crociani; Francesco Corradi; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2015-11-26       Impact factor: 3.397

3.  Impact of an Innovative Educational Strategy on Medication Appropriate Use and Length of Stay in Elderly Patients.

Authors:  Graziamaria Corbi; Giovanni Gambassi; Gennaro Pagano; Giusy Russomanno; Valeria Conti; Giuseppe Rengo; Dario Leosco; Roberto Bernabei; Amelia Filippelli; Nicola Ferrara
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Diabetes and CoViD-19: Experience from the frontline of Internal Medicine wards in Italy.

Authors:  A Montagnani; F Pieralli; P Gnerre; F Pomero; M Campanini; F Dentali; A Fontanella; D Manfellotto
Journal:  Diabetes Res Clin Pract       Date:  2020-07-18       Impact factor: 5.602

5.  Management of Hypothyroidism in Internal Medicine: Patient Profile and Effects of an Educational Programme in the Cluster-Randomized FADOI TIAMO Study.

Authors:  D Brancato; B Biondi; T M Attardo; A Fierro; M Nizzoli; R Vettor; E Monaco; R Romano; V Ariete; C Usai; E Zagarrì; M Campanini
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.